Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot MicroCT Study of Denosumab Versus Placebo in Postmenopausal Osteoporosis/Osteopenia
2005-005271-15Phase 2Terminated
- Sponsor
- Amgen
- Start
- Jun 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of denosumab in postmenopausal osteoporosis, osteopenia, sponsored by Amgen. Started Jun 2006; status: terminated.
02
Drugs
denosumab
03
Conditions
postmenopausal osteoporosisosteopenia
Beyond the preview
Go deeper on 2005-005271-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005271-15.